Morgan Stanley Call 150 iShares Nasdaq Biotechnology ETF 20.09.2024
/ DE000ME22T11
Morgan Stanley Call 150 iShares N.../ DE000ME22T11 /
| 09/07/2024 18:24:41 |
Chg.- |
Bid14:24:24 |
Ask14:24:24 |
Underlying |
Strike price |
Expiration date |
Option type |
| 1.16EUR |
- |
1.18
Bid Size: 100 |
1.44
Ask Size: 100 |
- |
150.00 - |
20/09/2024 |
Call |
Master data
| WKN: |
ME22T1 |
| Issuer: |
Morgan Stanley |
| Currency: |
EUR |
| Underlying: |
- |
| Type: |
Warrant |
| Option type: |
Call |
| Strike price: |
150.00 - |
| Maturity: |
20/09/2024 |
| Issue date: |
13/10/2023 |
| Last trading day: |
20/09/2024 |
| Ratio: |
1:1 |
| Exercise type: |
European |
| Quanto: |
No |
| Gearing: |
97.28 |
| Leverage: |
Yes |
Calculated values
| Fair value: |
0.04 |
| Intrinsic value: |
0.00 |
| Implied volatility: |
0.31 |
| Historic volatility: |
0.15 |
| Parity: |
-21.60 |
| Time value: |
1.32 |
| Break-even: |
151.32 |
| Moneyness: |
0.86 |
| Premium: |
0.18 |
| Premium p.a.: |
1.30 |
| Spread abs.: |
0.11 |
| Spread %: |
9.09% |
| Delta: |
0.15 |
| Theta: |
-0.03 |
| Omega: |
14.96 |
| Rho: |
0.04 |
Quote data
| Open: |
1.08 |
| High: |
1.16 |
| Low: |
1.08 |
| Previous Close: |
1.09 |
| Turnover: |
0.00 |
| Market phase: |
- |
All quotes in EUR
Performance
| 1 Week |
|
|
+48.72% |
| 1 Month |
|
|
+12.62% |
| 3 Months |
|
|
-6.45% |
| YTD |
|
|
-55.56% |
| 1 Year |
|
|
- |
| 3 Years |
|
|
- |
| 5 Years |
|
|
- |
| 10 Years |
|
|
- |
| 1W High / 1W Low: |
1.16 |
0.78 |
| 1M High / 1M Low: |
1.61 |
0.78 |
| 6M High / 6M Low: |
3.16 |
0.51 |
| High (YTD): |
27/02/2024 |
3.16 |
| Low (YTD): |
19/04/2024 |
0.51 |
| 52W High: |
- |
- |
| 52W Low: |
- |
- |
| Avg. price 1W: |
|
0.99 |
| Avg. volume 1W: |
|
0.00 |
| Avg. price 1M: |
|
1.09 |
| Avg. volume 1M: |
|
0.00 |
| Avg. price 6M: |
|
1.70 |
| Avg. volume 6M: |
|
0.00 |
| Avg. price 1Y: |
|
- |
| Avg. volume 1Y: |
|
- |
| Volatility 1M: |
|
261.54% |
| Volatility 6M: |
|
195.74% |
| Volatility 1Y: |
|
- |
| Volatility 3Y: |
|
- |
